F&P Healthcare and Ebos were caught in the souring on Aussie health stocks.
New recruit from HSBC credited with turnaround in fraud losses.
Clear path to profitability after strategic review, says CEO.
The NZX-listed company applied to liquidate business majority-owned by former chair and CEO.
Chair says company couldn’t have done ‘any better’ in communicating the news.
Concerns over Ryman’s build rate were stridently voiced at annual meeting this morning.
ASX demands response as buy-now, pay-later provider’s stock leaps 65%.
The $200m-plus Mānawa Bay complex will have 100 retail stores across 24,000sq m.
The corporate franchisee is conscious of staying relevant and cautious of raising menu prices amid cost pressures.
Kiwi companies warned to raise more capital now rather than wait.
